Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice

There is no effective protective vaccine against human toxoplasmosis, which is a potential threat to nearly a third of the world population. Vaccines based on virus-like particles (VLPs) have been highly successful in humans for many years, but have rarely been applied against Toxoplasma gondii infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jingjing, Zhou, Aihua, Sun, Xiahui, Sha, Wenchao, Ai, Kang, Pan, Ge, Zhou, Chunxue, Zhou, Huaiyu, Cong, Hua, He, Shenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449433/
https://www.ncbi.nlm.nih.gov/pubmed/30984177
http://dx.doi.org/10.3389/fimmu.2019.00592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449433/
https://www.ncbi.nlm.nih.gov/pubmed/30984177
http://dx.doi.org/10.3389/fimmu.2019.00592

Ejemplares similares